Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.625

-2.1%

9:43 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave K who wrote (152)	10/24/1998 10:21:00 AM
From: Shlepper	Read Replies (1) of 233

Hi Dave, Magainin's research in this area is great, but marketable products are still years away. A couple of months ago: "Magainin Publishes Data On Second Asthma Gene Candidate In The Journal of Biological Chemistry and Genomics" I think the next PR will be on the results of the trials with squalamine - probably within 2 - 3 months. Question right now is, does it make sense to continue buying at these low prices? When approval comes, the stock should jump appreciably. Downside is that in the unlikely scenario that the drug is not approved, then we have a penny stock. If approval does come as expected, I'm sure this board will get active again, and that our stress levels will be alleviated. Good Luck, Shep

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next